- Home
- LGO vs FATE Comparison
LGO vs FATE Comparison
Compare LGO & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- FATE
- Stock Information
- Founded
- LGO 1988
- FATE 2007
- Country
- LGO Canada
- FATE United States
- Employees
- LGO N/A
- FATE N/A
- Industry
- LGO
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LGO
- FATE Health Care
- Exchange
- LGO Nasdaq
- FATE Nasdaq
- Market Cap
- LGO 109.0M
- FATE 108.2M
- IPO Year
- LGO 2007
- FATE 2013
- Fundamental
- Price
- LGO $1.61
- FATE $1.11
- Analyst Decision
- LGO Strong Buy
- FATE Hold
- Analyst Count
- LGO 1
- FATE 8
- Target Price
- LGO $3.90
- FATE $5.43
- AVG Volume (30 Days)
- LGO 123.0K
- FATE 2.1M
- Earning Date
- LGO 05-14-2025
- FATE 05-08-2025
- Dividend Yield
- LGO N/A
- FATE N/A
- EPS Growth
- LGO N/A
- FATE N/A
- EPS
- LGO N/A
- FATE N/A
- Revenue
- LGO $124,920,000.00
- FATE $13,631,000.00
- Revenue This Year
- LGO $40.05
- FATE N/A
- Revenue Next Year
- LGO $16.56
- FATE N/A
- P/E Ratio
- LGO N/A
- FATE N/A
- Revenue Growth
- LGO N/A
- FATE N/A
- 52 Week Low
- LGO $1.12
- FATE $0.66
- 52 Week High
- LGO $2.84
- FATE $5.92
- Technical
- Relative Strength Index (RSI)
- LGO 50.55
- FATE 57.67
- Support Level
- LGO $1.44
- FATE $0.87
- Resistance Level
- LGO $1.59
- FATE $1.18
- Average True Range (ATR)
- LGO 0.16
- FATE 0.14
- MACD
- LGO 0.01
- FATE 0.04
- Stochastic Oscillator
- LGO 81.67
- FATE 86.54
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The Company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The Company has six operating segments: sales & trading wich generates key revenue, mine properties, corporate, exploration and evaluation properties, Largo Clean Energy, and Largo Physical Vanadium.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.